From: Effect of caffeine on delayed-onset muscle soreness: a meta-analysis of RCT
Author | Caffeine | Placebo | ||||
---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | |
A) VAS Pre-exercise | ||||||
Lorruama J | 9 | 4.7 | 3.67 | 9 | 4.9 | 3.37 |
Caitlin F | 9 | 0.149 | 0.179 | 9 | 0.298 | 0.417 |
Maridakis V | 9 | 2.66 | 1.56 | 9 | 1.82 | 1.08 |
UMD (95% CI) |  − 0.00 (− 0.51, 0.50) |  |  |  |  |  |
B) VAS Post-exercise | ||||||
Al-Nawaiseh AM | 11 | 3.927 | 2.235 | 11 | 4.009 | 1.956 |
Maridakis V | 9 | 1.39 | 1.31 | 9 | 1.63 | 0.89 |
UMD (95% CI) |  − 0.20 (− 1.09, 0.69) |  |  |  |  |  |
C) VAS at 24Â h | ||||||
Chen HY | 10 | 0.7525 | 0.1303 | 10 | 0.865 | 0.069 |
Lorruama J | 9 | 5 | 3.38 | 9 | 5.5 | 3.08 |
Caitlin F | 9 | 2.59 | 1.25 | 9 | 3.571 | 0.506 |
Al-Nawaiseh AM | 11 | 5.506 | 1.64 | 11 | 5.022 | 1.38 |
Maridakis V | 9 | 0.95 | 1.03 | 9 | 2.2 | 1.03 |
Nobahar M | 8 | 2.5 | 0.175 | 8 | 5 | 0.175 |
Caldwell AR | 12 | 1.45 | 2.45 | 18 | 2.78 | 1.67 |
UMD (95% CI) |  − 0.92 (− 2.20, 0.36) |  |  |  |  |  |
D) VAS at 48Â h | ||||||
Caitlin F | 9 | 2.5 | 1.25 | 9 | 4.107 | 0.506 |
Al-Nawaiseh AM | 11 | 5.3 | 2.204 | 11 | 3.973 | 2.207 |
Maridakis V | 9 | 0.56 | 1.02 | 9 | 1.81 | 1.01 |
Caldwell AR | 12 | 0.45 | 0.78 | 18 | 1.78 | 1.33 |
UMD (95% CI) |  − 1.02 (− 1.86, − 0.19) |  |  |  |  |  |
E) VAS at 72Â h | ||||||
Caitlin F | 9 | 1.369 | 0.476 | 9 | 1.786 | 0.923 |
Caldwell AR | 12 | 1 | 0.88 | 18 | 1.22 | 1.1 |
UMD (95% CI) | 0.0 (− 0.36, 0.36) |  |  |  |  |  |
F) VAS at 96Â h | ||||||
Caitlin F | 9 | 0.952 | 0.774 | 9 | 0.774 | 0.833 |
UMD (95% CI) | 0.18 (− 0.56, 0.96) |  |  |  |  |  |